A Brief Outlook on Pharmacogenetics (PGx): Focus in MicroRNAs (miRNAs) and Cancer Stem Cells (CSCs)

Ferry Sandra

Abstract


It has been known that there are differences in response to medications both in terms of clinical activity and side effects. Among all influencing factors, genetic variation has been considered to play a crucial part. By genetic investigation, the differences in drug metabolism, transport and target could be disclosed. Termed as “pharmacogenetics (PGx)”, that focuses on the variants within one or more candidate genes. Genetic tests have been started for screening polymorphisms prior to drug prescription, moreover many biomarkers were developed in oncology. Recent PGx investigations have been conducted to identify mRNAs, microRNAs (miRNAs) and other downstream signals that are affected by variation in genes that might cause drug response variability. Another intriguing study related to PGx in cancer stem cells (CSCs) has recently aroused. CSC shows more resistant behavior to drug. CSCs are subpopulation of cells, which share some same markers with stem cells. CSC can induce specific signal transduction pathways. Variation in genes affect CSCs activity are generally neglected in the past PGx studies. This could be one of the explanation why past PGx studies in cancer cell do not achieve optimal clinical outcome. 

Keywords : pharmacogenetics, pharmacogenomics, microRNAs, cancer stem cells


Full Text:

PDF

References


Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., et al., 2008, Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer, Cancer Res., 68(15), 6162-6170. CrossRef

Amado, R.G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D.J., et al., 2008, Wildtype KRAS is Required for Panitumumab Efficacy in Patients with Metastatic Colorectal Cancer, J.Clin. Oncol., 26(10), 1626-1634. CrossRef

Amtha, R., Gunardi, I., Sandra, F., Ernawati, D.S., 2015, Expression of CD133 in Carious Premalignant and Proliferative Lesions, Dent J., 48(2), 65-69. CrossRef

Artells, R., Moreno, I., Díaz, T., Martínez, F., Gel, B., Navarro, A., et al., 2010, Tumour CD133 mRNA Expression and Clinical Outcome in Surgically Resected Colorectal Cancer Patients, Eur. J. Cancer, 46, 642-649. CrossRef

Bonnet, D. and Dick, J.E., 1997, Human Acute Myeloid Leukemia is Organized as A Hierarchy that Originates from A Primitive Hematopoietic Cell, Nat. Med., 3(7), 730-737. CrossRef

Caldwell, M.D., Awad, T., Johnson, J.A., Gage, B.F., Falkowski, M., Gardina, P., et al., 2008, CYP4F2 Genetic Variant Alters Required Warfarin Dose, Blood, 111(8), 4106-4112. CrossRef

Celebiler Cavusoglu, A., Kilic, Y., Saydam, S., Canda, T., Başkan, Z., Sevinc, A.I., et al., 2009, Predicting Invasive Phenotype with CDH1, CDH13, CD44, and TIMP3 Gene Expression in Primary Breast Cancer, Cancer Sci., 100(2), 2341-2345. CrossRef

Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I. and Ruiz i Altaba, A., 2007, HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-renewal, and Tumorigenicity, Curr. Biol., 17(2), 165-172. CrossRef

Crea, F., Duhagon, M.A., Farrar, W.L. and Danesi, R., 2011, Pharmacogenomics and Cancer Stem Cells: A Changing Landscape?, Trends Pharmacol. Sci., 32(8), 487-494. CrossRef

Ehtesham, M., Sarangi, A., Valadez, J.G., Chanthaphaychith, S., Becher, M.W., Abel, T.W., et al., 2007, Ligand-dependent Activation of the Hedgehog Pathway in Glioma Progenitor Cells, Oncogene, 26(39), 5752-5761. CrossRef

Garzon, R., Calin, G.A., Croce, C.M., 2009, MicroRNAs in Cancer, Annu. Rev. Med., 60, 167-179. CrossRef

Garzon, R., Volinia, S., Liu, C.G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., et al., 2008, Microrna Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia, Blood, 111(6), 3183-3189. CrossRef

Griffiths-Jones, S., Saini, H.K., van Dongen, S. and Enright, A.J., 2008, Mirbase: Tools for MicroRNA Genomics, Nucleic Acids Res., 36(Database issue): D154-D158. CrossRef

He, L. and Gregory, J.H., 2004, Microrna: Small RNAs with A Big Role in Gene Regulation, Nat. Rev. Genet., 5(7), 522-531. CrossRef

Karapetis, C.S., Khambata-Ford, S., Jonker, D.J., O’Callaghan, C.J., Tu, D., Tebbutt, N.C., et al., 2008, K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer, N.Engl. J. Med., 359(17), 1757-1765. CrossRef

Khoshnaw, S.M., Green, A.R., Powe, D.G. and Ellis, I.O., 2009, MicroRNA Involvement in the Pathogenesis and Management of Breast Cancer, J. Clin. Pathol., 62(5), 422-428. CrossRef

Lee, C.T., Risom, T. and Strauss, W.M., 2007, Evolutionary Conservation of MicroRNA Regulatory Circuits: An Examination of MicroRNA Gene Complexity and Conserved MicroRNAtarget Interactions through Metazoan Phylogeny, DNA Cell. Biol., 26(4), 209-18. CrossRef

Madian, A.G., Wheeler, H.E., Jones, R.B. and Dolan, M.E., 2012, Relating Human Genetic Variation to Variation in Drug Responses, Trends. Genet., 28(10), 487-495. CrossRef

Mott, J.L., 2009, MicroRNAs Involved in Tumor Suppressor and Oncogene Pathways: Implications for Hepatobiliary Neoplasia, Hepatology, 50(2), 630-637. CrossRef

Okayama, H., Kumamoto, K., Saitou, K., Hayase, S., Kofunato, Y., Sato, Y., et al., 2009, CD44v6, MMP-7 and Nuclear Cdx2 are Significant Biomarkers for Prediction of Lymph Node Metastasis in Primary Gastric Cancer, Oncol. Rep., 22(4), 745-755. CrossRef

Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Todaro, M., et al., 2008, Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme, Clin. Cancer Res., 14(24), 8205-8212. CrossRef

Rieder, M.J., Reiner, A.P., Gage, B.F., Nickerson, D.A., Eby, C.S., McLeod, H.L., et al., 2005, Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose, N. Engl. J. Med., 352(22), 2285-2293.

href="https://doi.org/10.1056/nejmoa044503">CrossRef

Salari, K., Watkins, H. and Ashley, E.A., 2012, Personalized Medicine: Hope or Hype?, Eur.Heart J., 33(13), 1564-1570. CrossRef

Salnikov, A.V., Gladkich, J., Moldenhauer, G., Volm, M., Mattern, J. and Herr, I., 2010, CD133 is Indicative for A Resistance Phenotype but Does Not Represent A Prognostic Marker for Survival of Non-small Cell Lung Cancer Patients, Int. J.Cancer, 126(4), 950-958.50. CrossRef

Sconce, E.A., Khan, T.I., Wynne, H.A., Avery, P., Monkhouse, L., King, B.P., et al., 2005, The Impact of CYP2C9 and VKORC1 Genetic Polymorphism and Patient Characteristics upon Warfarin Dose Requirements: Proposal for A New Dosing Regimen, Blood, 106(7), 2329-2333. CrossRef

Shen, J., Ambrosone, C.B., DiCioccio, R.A., Odunsi, K., Lele, S.B. and Zhao, H., 2008, A Functional Polymorphism in the Mir-146a Gene and Age of Familial Breast/Ovarian Cancer Diagnosis, Carcinogenesis, 29(10), 1963-1966. CrossRef

Takahashi, H., Wilkinson, G.R., Nutescu, E.A., Morita, T., Ritchie, M.D., Scordo, M.G., et al., 2006, Different Contributions of Polymorphisms in VKORC1 and CYP2C9 to Intra- and Interpopulation Differences in Maintenance Dose of Warfarin in Japanese, Caucasians and African-Americans, Pharmacogenet. Genomics., 16(2), 101-110. CrossRef

To, K.K., Robey, R.W., Knutsen, T., Zhan, Z., Ried, T. and Bates, S.E., 2009, Escape from hsamir-519c Enables Drugresistant Cells to Maintain High Expression of abcg2, Mol. Cancer Ther., 8(10), 2959-2968. CrossRef

Ueda, T., Volinia, S., Okumura, H., Shimizu, M., Taccioli, C., Rossi, S., et al., 2010, Relation between MicroRNA Expression and Progression and Prognosis of Gastric Cancer: A MicroRNA Expression Analysis, Lancet Oncol., 11(2), 136-146. CrossRef

Van Cutsem, E., Kohne, C.H., Hitre, E., Zaluski, J., Chang-Chien, C.R., Makhson, A., et al., 2009, Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer, N. Engl. J. Med., 360(14), 1408-1417. CrossRef

Wijaya, L., Agustina, D., Lizandi, A.O., Kartawinata, M.M. and Sandra, F., 2011, Reversing Breast Cancer Stem Cell into Breast Somatic Stem Cell, Curr. Pharm. Biotechnol., 12(2), 189-195. CrossRef

Wu, X., Piper-Hunter, M.G., Crawford, M., Nuovo, G.J., Marsh, C.B., Otterson, G.A., et al., 2009, MicroRNAs in the Pathogenesis of Lung Cancer, J. Thorac Oncol., 4(8), 1028-1034. CrossRef

Zhang, W. and Dolan, M.E., 2010, The Emerging Role of microRNAs in Drug Response, Curr. Opin. Mol. Ther., 12(6), 695-702. Link

Zhu, H., Wu, H., Liu, X., Evans, B.R., Medina, D.J., Liu, C.G. and Yang, J.M., 2008, Role of MicroRNA mir-27a and mir-451 in the Regulation of mdr1/p- Glycoprotein Expression in Human Cancer Cells, Biochem. Pharmacol., 76(5), 582-588. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev10iss1pp46-50

Copyright (c) 2019 Ferry Sandra

Indexed by:

                  

               

 

Indonesian Society for Cancer Chemoprevention